Trials / Completed
CompletedNCT02654093
A Drug-drug Interaction Study of DP-R213
A Randomized, Open-label, Single-dose, 3-period, 6-sequence Crossover Study to Evaluate the Safety and the Pharmacokinetics After Oral Concurrent Administration of Raloxifene, Cholecalciferol in Healthy Korean Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Alvogen Korea · Industry
- Sex
- Male
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to learn about the effect of raloxifene on how the body absorbs and processes cholecalciferol and how cholecalciferol affects raloxifene when they are taken together.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cholecalciferol | |
| DRUG | Raloxifene | |
| DRUG | Cholecalciferol and Raloxifene co-administration |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2016-01-13
- Last updated
- 2016-03-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02654093. Inclusion in this directory is not an endorsement.